Cystic fibrosis related diabetes is not associated with maximal aerobic exercise capacity in cystic fibrosis: a cross-sectional analysis of an international multicenter trial

被引:3
|
作者
Radtke, Thomas [1 ,11 ]
Kriemler, Susi [1 ]
Stein, Lothar [2 ]
Karila, Chantal [3 ]
Urquhart, Don S. [4 ]
Orenstein, David M. [5 ]
Lands, Larry C. [6 ]
Schindler, Christian [7 ,8 ]
Eber, Ernst [9 ]
Haile, Sarah R. [1 ]
Hebestreit, Helge [10 ]
机构
[1] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland
[2] Hannover Med Sch, Inst Sports Med, Hannover, Germany
[3] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Serv Pneumol & Allergol Pediat, Paris, France
[4] Royal Hosp Children & Young People, Dept Paediat Resp & Sleep Med, Edinburgh, Scotland
[5] Childrens Hosp Pittsburgh UPMC, Dept Pediat, Pittsburgh, PA USA
[6] McGill Univ Hlth, Montreal Childrens Hosp, Montreal, PQ, Canada
[7] Univ Basel, Swiss Trop & Publ Hlth Inst, Basel, Switzerland
[8] Univ Basel, Fac Med, Basel, Switzerland
[9] Med Univ Graz, Dept Pediat & Adolescent Med, Graz, Austria
[10] Univ Hosp Wurzburg, Paediat Dept, Wurzburg, Germany
[11] Univ Zurich, Hirschengraben 84, CH-8001 Zurich, Switzerland
基金
瑞士国家科学基金会;
关键词
Peak oxygen uptake; Cystic fibrosis related diabetes; Physical activity; Dysglycaemia; Exercise capacity; POSITION STATEMENT; PHYSICAL-ACTIVITY; GENOTYPE; STANDARDIZATION; PREVALENCE; TOLERANCE; ADULTS;
D O I
10.1016/j.jcf.2022.06.012
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Previous studies have reported differences in aerobic exercise capacity, expressed as peak oxygen uptake (VO2peak), between people with and without cystic fibrosis (CF) related diabetes (CFRD). However, none of the studies controlled for the potential influence of physical activity on VO2peak. We investigated associations between CFRD and VO2peak following rigorous control for confounders including objectively measured physical activity. Methods: Baseline data from the international multicenter trial ACTIVATE-CF with participants >= 12 years performing up to 4 h per week of vigorous physical activity were used for this project. Multivariable models were computed to study associations between CFRD and VO2peak (mL.min-1) adjusting for a set of pre-defined covariates: age, sex, weight, forced expiratory volume in 1 s (FEV1), breathing reserve index, Pseudomonas aeruginosa infection, and physical activity (aerobic step counts from pedometry). Variables were selected based on their potential confounding effect on the association between VO2peak and CFRD. Results: Among 117 randomized individuals, 103 (52% female) had a maximal exercise test and were included in the analysis. Participants with ( n = 19) and without ( n = 84) CFRD did not differ in FEV1, physical activity, nutritional status, and other clinical characteristics. There were also no differences in VO2peak (mL.min-1or mL.kg-1.min -1 or% predicted). In the final multivariable model, all pre-defined co-variates were significant predictors of VO2peak (mL.min -1), however CFRD [coefficient 82.1, 95% CI-69.5 to 233.8, p = 0.28] was not. Conclusions: This study suggests no meaningful differences in VO2peak between people with and without CFRD given comparable levels of physical activity. (c) 2022 Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.
引用
收藏
页码:31 / 38
页数:8
相关论文
共 50 条
  • [41] Cystic fibrosis (cf) and ovarian reserve: A cross-sectional study examining serum anti-mullerian hormone (amh) in young women
    Schram, C. A.
    Stephenson, A. L.
    Hannam, T. G.
    Tullis, E.
    JOURNAL OF CYSTIC FIBROSIS, 2015, 14 (03) : 398 - 402
  • [42] Screening Methods for Diagnosing Cystic Fibrosis-Related Diabetes: A Network Meta-Analysis of Diagnostic Accuracy Studies
    Izsak, Vera Dora
    Soos, Alexandra
    Szakacs, Zsolt
    Hegyi, Peter
    Juhasz, Mark Felix
    Varannai, Orsolya
    Martonosi, Agnes Rita
    Foldi, Maria
    Kozma, Alexandra
    Vajda, Zsolt
    Shaw, James A. M.
    Parniczky, Andrea
    BIOMOLECULES, 2021, 11 (04)
  • [43] Peripheral Muscle Function and Body Composition in People With Cystic Fibrosis on Elexacaftor/Tezacaftor/Ivacaftor: A Cross-Sectional Single-Centre Study
    Clayton, Lauren J.
    Shepherd, Anthony I.
    Corbett, Jo
    Gruet, Mathieu
    Connett, Gary
    Allenby, Mark
    Legg, Julian
    Daniels, Thomas
    Urquhart, Don S.
    Saynor, Zoe L.
    PEDIATRIC PULMONOLOGY, 2025, 60 (03)
  • [44] The Correlation of Health-Related Quality of Life with Cystic Fibrosis Severity Markers in Chest CT Scan and 6-Minute Walk Test: A Cross-Sectional Study
    Modaresi, Mohammadreza
    Roshanzamir, Zahra
    Shirzadi, Rohola
    INDIAN JOURNAL OF PEDIATRICS, 2022, 89 (02) : 113 - 117
  • [45] Feasibility and efficacy of combined pancreatic islet-lung transplantation in cystic fibrosis-related diabetes-PIM study: A multicenter phase 1-2 trial
    Rakotoarisoa, Luc
    Wagner, Clothilde
    Munch, Marion
    Picard, Benjamin Renaud
    Grenet, Dominique
    Olland, Anne
    Greget, Michel
    Enescu, Iulian
    Bouilloud, Florence
    Bonnette, Pierre
    Guth, Axel
    Bosco, Domenico
    Mercier, Catherine
    Rabilloud, Muriel
    Berney, Thierry
    Benhamou, Pierre Yves
    Massard, Gilbert
    Camilo, Coralie
    Colin, Cyrille
    Arnold, Cecile
    Kessler, Romain
    Kessler, Laurence
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 (07) : 1861 - 1872
  • [46] A glycosylated hemoglobin A1c above 6% (42 mmol/mol) is associated with a high risk of developing Cystic Fibrosis-Related Diabetes and a lower probability of weight gain in both adults and children with Cystic Fibrosis
    Potter, Kathryn J.
    Racine, Florence
    Bonhoure, Anne
    Boudreau, Valerie
    Belanger, Noemie
    Coriati, Adele
    Shohoudi, Azadeh
    Lavoie, Annick
    Senior, Peter A.
    Mailhot, Genevieve
    Rabasa-Lhoret, Remi
    DIABETES & METABOLISM, 2023, 49 (04)
  • [47] Effects of treadmill exercise versus Flutter® on respiratory flow and sputum properties in adults with cystic fibrosis: a randomised, controlled, cross-over trial
    Dwyer, Tiffany J.
    Zainuldin, Rahizan
    Daviskas, Evangelia
    Bye, Peter T. P.
    Alison, Jennifer A.
    BMC PULMONARY MEDICINE, 2017, 17
  • [48] Measurement properties of the one-minute sit-to-stand test in children and adolescents with cystic fibrosis: A multicenter randomized cross-over trial
    Combret, Yann
    Boujibar, Fairuz
    Gennari, Charlotte
    Medrinal, Clement
    Sicinski, Sophie
    Bonnevie, Tristan
    Gravier, Francis-Edouard
    Laurans, Muriel
    Marguet, Christophe
    Le Roux, Pascal
    Lamia, Bouchra
    Prieur, Guillaume
    Reychler, Gregory
    PLOS ONE, 2021, 16 (02):
  • [49] Bone and body composition analyzed by Dual-energy X-ray Absorptiometry (DXA) in clinical and nutritional evaluation of young patients with Cystic Fibrosis: a cross-sectional study
    Lucidi, Vincenzina
    Bizzarri, Carla
    Alghisi, Federico
    Bella, Sergio
    Russo, Beatrice
    Ubertini, Graziamaria
    Cappa, Marco
    BMC PEDIATRICS, 2009, 9 : 61
  • [50] Patient-reported outcomes in patients with cystic fibrosis with a G551D mutation on ivacaftor treatment: results from a cross-sectional study
    Bell, Scott C.
    Mainz, Jochen G.
    MacGregor, Gordon
    Madge, Susan
    Macey, Julie
    Fridman, Moshe
    Suthoff, Ellison D.
    Narayanan, Siva
    Kinnman, Nils
    BMC PULMONARY MEDICINE, 2019, 19 (01)